Rubra Medicaments Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 2.6 million compared to INR 0.875 million a year ago. Revenue was INR 2.6 million compared to INR 0.875 million a year ago. Net income was INR 0.141 million compared to INR 0.061 million a year ago. Basic earnings per share from continuing operations was INR 0.03 compared to INR 0.01 a year ago. Diluted earnings per share from continuing operations was INR 0.03 compared to INR 0.01 a year ago. Basic earnings per share was INR 0.03 compared to INR 0.01 a year ago. Diluted earnings per share was INR 0.03 compared to INR 0.01 a year ago. For the six months, sales was INR 9.56 million compared to INR 0.875 million a year ago. Revenue was INR 9.56 million compared to INR 0.875 million a year ago. Net income was INR 0.212 million compared to INR 0.001 million a year ago. Basic earnings per share from continuing operations was INR 0.04. Diluted earnings per share from continuing operations was INR 0.04. Basic earnings per share was INR 0.04. Diluted earnings per share was INR 0.04.